Kate O'Brien, Director of the Department of Immunization, Vaccines and Biologicals at WHO The fight against misinformation ...
Recommendation for adults and adolescents based on Phase 3 trials showing Dupixent significantly reduced itch and hives at 24 weeks compared to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback